Onassis Holding Corp, a wellness holding company has signed a binding acquisition agreement to buy its MGC Nutraceuticals subsidiary which develops CBD and hemp Neutraceuticals. MGC Nutraceuticals subsidiary produces food supplements and derma products in Europe. Under the agreement, MGC Pharma will receive US$6 million in shares of Onassis Holdings. Additionally, Onassis signed an exclusive supply agreement for the provision of MGC pharma CBD, raw materials, and will get the proprietary production intellectual property for future production and manufacturing.
Sean Hocking, Cannabis Law Report, 11/03/2020 20:02:10